ANXA2 and neoplasm: To confirm this result, some of NOD SCID mice initially injected with shANXA2 MDA-MB-231 cells, which did not show tumor development after the first injection (Fig. 5B, black arrow), were injected a second time with control or ANXA2-deficient MDA-MB-231 cells (Fig. 5C, D).